After 5 Years Cervical Cancer Vaccine Tested in Brazil and US Keeps Working

Young woman gets a cervical cancer vaccine shot As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress. While HPV vaccine efforts had the "benefit" of a viral source for the disease, other researchers are developing vaccines for cancers that are not virally based, in an effort to coax the immune system into attacking cancerous cells.

Today at the 2007 Annual Meeting of the American Association for Cancer Research, presentations on ongoing HPV trials and other new approaches to stimulating the immune system are injecting momentum into cancer vaccine research.

Ongoing evaluation of a phase II trial of a human papillomavirus vaccine, developed to prevent cervical cancer, shows that the vaccine continues to protect against HPV types 16 and 18 at five and a half years into the study, according to researchers from the University of Louisville. Their findings also show that the vaccine offers significant cross-protection for HPV types 45 and 31.

The study follows 1113 women between the ages of 15 and 25 in North America and Brazil randomized to receive three doses of either the vaccine or the control. The vaccine, made by GlaxoSmithKline, which funded the study, is designed to protect against two strains of HPV, types 16 and 18, which together are thought to cause nearly 72 percent of all cases of cervical cancer.

At over five years into the study’s follow-up, the researchers found that approximately 98 percent of subjects still maintained protection against HPV types 16 and 18. Regardless of HPV status, the vaccine also appears to prevent most occurrences of cervical intraepithelial neoplasia lesions – abnormal, precancerous cell growths found in the cervix.

They also found that the vaccination offered significant protection against genetically similar viruses. They determined the vaccine to be 88 percent effective against HPV type 45 and 54 percent effective against HPV type 31.

"Overall, it is not a surprise that the vaccine offers protection against additional types of human papillomavirus, as they are all related genetically," said Stanley Gall, M.D., professor at the University of Louisville. "However, as you get genetically farther from types 16 and 18, you would expect to see less cross-protection."

According to Dr. Gall, effective preventative treatment with the vaccine will depend on the long-term and broad protection the vaccine can offer against cancer-causing HPV types.

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Brazil’s Ruling PT Party Won’t Field House Speaker Candidate

Brazilian Deputy Aldo Rebelo, from the Partido Comunista do Brasil (PC do B), will ...

Foreign Reserves and Investors Way Up in Brazil

Brazil’s international reserves reached US$ 62 billion at the end of the first quarter ...

Despite Sales Increase Brazil’s Chicken Exporters Are Losing Money

Brazilian chicken exports yielded US$ 2.145 billion in the first half of this year, ...

Researchers in Brazil Get US$ 2.1 Million to Study AIDS and STDs

Beginning this month, researchers from all over Brazil will begin to receive funding from ...

Letters

Here like there Reading your “Red Tape Addiction” article in the November issue made ...

Polls Show Lula Will Win Reelection in Brazil Hands Down

Brazilian President Luiz Inácio Lula da Silva stands out as an undefeatable candidate for ...

Americans and Brazilian Immigrants Flock South in Search of Brazilian Dream

Brazilian immigrants are returning home to a bustling economy that offers better financial opportunities ...

34 Countries at Brazil’s Arab Summit. Only Half Sent Chief of State

The summit for South American and Arab countries only starts today in BrasÀ­lia, capital ...

Like Our Parents

Students and their parents have rock as their first musical choice. Leonardo da Vinci ...

Brazil Ready to Tap Amazon for Drugs and the Land for Fuel

Ahead of US President George Bush's visit, Brazil announced plans to invest almost US$ ...